Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks.


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01557712

Organisation Name: University Hospital, Grenoble

Overal Status: Completed

Start Date: March 2012

Last Update: February 24, 2017

Lead Sponsor: University Hospital, Grenoble

Brief Summary: The objective of this study is to evaluate the effectiveness of ketamine (infusion of 0.5mg/kg) and venlafaxine compared to the use of venlafaxine alone in the treatment of major depression (MADRS score ≥ 20 ) to six weeks of treatment.

Conditions:
  • Major Depressive Disorder


Total execution time in seconds: 0.15223217010498